The novel approach of the medication represents a exciting breakthrough in the care of the condition. Unlike existing drugs, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – providing https://tirzepatidepeptide306682.idblogmaker.com/40709210/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment